Mirae Asset Global Investments Co., Ltd. Ab Cellera Biologics Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 11,530 shares of ABCL stock, worth $67,335. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,530
Previous 9,929
16.12%
Holding current value
$67,335
Previous $22,000
77.27%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ABCL
# of Institutions
150Shares Held
114MCall Options Held
488KPut Options Held
476K-
Baker Bros. Advisors LP New York, NY27.5MShares$161 Million0.96% of portfolio
-
Capital World Investors Los Angeles, CA13.4MShares$78 Million0.01% of portfolio
-
Baillie Gifford & CO10.4MShares$60.5 Million0.03% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL8.47MShares$49.5 Million0.01% of portfolio
-
Credit Suisse Ag Zurich, V84.55MShares$26.6 Million0.02% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $1.67B
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...